Open AccessEfficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
Author(s) -
Thomas Danne,
William V. Tamborlane,
Oleg Malievsky,
Denise Reis Franco,
Tomoyuki Kawamura,
Marek Demissie,
Elisabeth Niemoeller,
Harmonie Goyeau,
Marek Wardęcki,
Tadej Battelino
Publication year - 2020
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc19-1926
Subject(s) - medicine , insulin glargine , diabetes mellitus , endocrinology , insulin , type 2 diabetes
To compare efficacy and safety of insulin glargine 300 units/mL (Gla-300) and 100 units/mL (Gla-100) in children and adolescents (6-17 years old) with type 1 diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom